Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 16.38% |
| A M R CP | AAMRQ | 8.10% |
| JAZZ PHARMAC | JAZZ | 6.83% |
| SANTARUS INC | SNTS | 6.50% |
| OLD SECOND B | OSBC | 5.64% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Industrial gas producer and supplier, Praxair Inc. ( PX - Analyst Report ) recently priced $900 million worth of notes, offered under the company’s universal shelf registration statement. The offering will consummate on Feb 21, 2013.
The current notes issuance will be given effect through the issuing of $400 million of 0.75% notes due in 2016 and $500 million of 2.70% notes due in 2023, expected to yield 0.771% and 2.740% on maturity, respectively. The offer price for 0.75% notes has been fixed at 99.938% of principal amount while at 99.652% for 2.70% notes.
Interest on these notes will be paid semi-annually with the first payment falling due on August 21, 2013. Praxair intends to use the proceeds from the issuance for repaying short-term debt, repurchase of shares, acquisitions and for general corporate purposes.
Prior to this issue, Praxair had raised $700 million in November 2012, $500 million in August 2012 and $600 million in February 2012.
Exiting 2012, Praxair’s long-term debt balance stood at $6,685.0 million, up 4.6% sequentially. Interest paid during the year totaled $141 million. Rising debt burden will increase the company’s financial obligations all the more in the quarters ahead.
The current Zacks Consensus Estimate for the first quarter of 2013 is $1.39, representing a year-over-year increase of 0.4%. Estimates for years 2013 and 2014 are $6.00 and $6.82, reflecting annual growth of 7.7% and 13.6%, respectively.
The stock currently carries a Zacks Rank #3 (Hold). Other stocks to watch out for in the industry are Arkema S.A. ( ARKAY ) , with a Zacks Rank #1 (Strong Buy) and BASF SE ( BASFY ) and Air Products & Chemicals Inc. ( APD - Analyst Report ) , each with a Zacks Rank #2 (Buy).
Read the full reports :
on BASFY
Analyst Report on PX
Analyst Report on APD
on ARKAY